Clinical Trials on Healthy Subject

Total 20598 results

Trius Therapeutics LLC

Completed

Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults (SAD/MAD)

Healthy Subjects

United States
Minerva Neurosciences

Completed

A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers

Healthy Subjects

Ireland
Duke University

Completed

TMS Modulation of Insula-related Brain Networks (TMS_INS)

Healthy Subjects

United States
ViiV Healthcare
Pfizer

Completed

THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC

Healthy Subjects

United States
Egalet Ltd

Completed

Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy Subjects

Healthy Subjects

United Kingdom
Eisai Co., Ltd.

Completed

Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects

Healthy Subjects

United States
Actelion

Completed

Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects

Healthy Subjects

France
GlaxoSmithKline

Completed

A Study of GSK1325760A in Healthy Japanese Subjects

Healthy Subjects
Max Planck Institute for Human Cognitive and Brain...
European Research Council

Completed

Plasticity of the Compassionate Brain

Healthy Subjects

Germany
Elcelyx Therapeutics, Inc.

Completed

Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects

Healthy Subjects
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions

Healthy Subjects
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.

Healthy Subjects
Actelion

Completed

Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects

Healthy Subjects

France
Laboratoires Innothera
Biotrial

Completed

Study of the Effect of Elastic Compression (French Class III) on Water Balance Change in Healthy Subjects

Healthy Subjects

France
Lpath, Inc.

Completed

A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers

Healthy Subjects

United States
Actelion

Completed

Comparison of the Pharmacokinetic Properties of Two Tablet Formulations of Macitentan in Healthy Adults

Healthy Subjects

Czech Republic
Ocular Therapeutix, Inc.

Unknown

Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug

Healthy Subjects
Hospital Miguel Servet

Completed

Efficacy of 8 vs 4 Sessions Mindfulness-based Programs in a Non-clinical Population

Healthy Subjects
Eisai Inc.

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects

Healthy Subjects

United States
Eisai Inc.

Completed

A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil

Healthy Subjects

United States
UCB Pharma SA
Parexel

Completed

A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects

Healthy Subjects

China
Eisai Co., Ltd.

Completed

A Study of E2022 Tape Formulation (Overlay-integrated E2022 18 mg Tape Formulation) for Different Application Sites and Intervals in Japanese Healthy Elderly Males

Healthy Subjects

Japan
424 General Military Hospital

Completed

Circulating Levels of Irisin in Healthy Young Subjects (IRISSAS)

Healthy Subjects

Greece
GlaxoSmithKline

Completed

A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions

Healthy Subjects

United States
GlaxoSmithKline

Completed

Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend

Healthy Subjects

United States
Ming-Tsang Wu

Completed

Behaviour Intervention to Decrease Melamine Exposure (Bidme)

Healthy Subjects

Taiwan
Leatherhead Food Research
University of Sussex

Completed

The Effect of Sensory-enhanced Beverages on Satiety Following Repeated Exposures

Healthy Subjects

United Kingdom
MedImmune LLC

Completed

A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers

Healthy Subjects

United States
University of Lausanne
Centre Hospitalier Universitaire Vaudois; University of Bern

Completed

Effects of Exercise on Fructose Metabolism (FruEx2)

Healthy Subjects

Switzerland
American Medical Systems
Quintiles, Inc.

Completed

JetTouch Injection System to Deliver Saline Into the Bladder Wall of Healthy Volunteers

Healthy Subjects

United Kingdom
Alexion Pharmaceuticals

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects

Healthy Subjects

United States
Unilever R&D

Completed

Assessment of the Relative Increase in Bioavailability of (Non-) Nutrients From a Mixed Salad by Adding Fat Containing Dressing

Healthy Subjects

Brazil
Lexicon Pharmaceuticals

Completed

Study to Evaluate the Effect of Single Doses of LX4211 and Canagliflozin on Intestinal Glucose Absorption in Healthy Adult Subjects

Healthy Subjects

United States
Cliniques universitaires Saint-Luc- Université...

Completed

Effect of Drug Targeting Nebulization on Lung Deposition

Healthy Subjects

Belgium
National Taiwan University Hospital
National Science Council, Taiwan

Completed

The Pharmacokinetic Study of Red Yeast Rice Capsule Compared to Lovastatin Tablet in Healthy Subjects

Healthy Subjects

Taiwan
Charite University, Berlin, Germany
Karl and Veronica Carstens Foundation

Completed

Homeopathic Drug Proving Trial (HAMSV)

Healthy Subjects

Germany
AstraZeneca

Completed

Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214 (TC-5214)

Healthy Subjects

United States
Astellas Pharma Inc

Completed

Drug-drug Interaction Study With ASP1941 and Glimepiride

Healthy Subjects

Netherlands
Merz Pharmaceuticals GmbH

Completed

Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects

Healthy Subjects

Germany
Merz Pharmaceuticals GmbH

Completed

Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane

Healthy Subjects

Germany
GlaxoSmithKline

Completed

Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.

Healthy Subjects

Canada
Hvidovre University Hospital

Completed

Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism

Healthy Subjects

Denmark
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Single Doses of ILV-095 in Healthy Subjects

Healthy Subjects

United States
University Hospital, Strasbourg, France

Completed

Exploring the Effects of Diazepam and Lorazepam (ibid)

Healthy Subjects

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate

Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Pharmacokinetics (PK), and Pharmacodynamices (PD) of HSD-016

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating BLI-489 and Piperacillin in Healthy Subjects

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Pharmacokinetics (PK) of Ascending Single IV Doses of ERB-257 in Healthy Japanese Males

Healthy Subjects

Japan

3

Subscribe